These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

508 related articles for article (PubMed ID: 16980981)

  • 41. Comparison of virulence between the Yersinia pestis Microtus 201, an avirulent strain to humans, and the vaccine strain EV in rhesus macaques, Macaca mulatta.
    Tian G; Qi Z; Qiu Y; Wu X; Zhang Q; Yang X; Xin Y; He J; Bi Y; Wang Q; Zhou J; Fan Y; Zhou Y; Jiang Y; Yang R; Wang X
    Hum Vaccin Immunother; 2014; 10(12):3552-60. PubMed ID: 25483697
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Structural features and structural variability of the lipopolysaccharide of Yersinia pestis, the cause of plague.
    Knirel YA; Dentovskaya SV; Senchenkova SN; Shaikhutdinova RZ; Kocharova NA; Anisimov AP
    J Endotoxin Res; 2006; 12(1):3-9. PubMed ID: 16420739
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Protection against aerosolized Yersinia pestis challenge following homologous and heterologous prime-boost with recombinant plague antigens.
    Glynn A; Roy CJ; Powell BS; Adamovicz JJ; Freytag LC; Clements JD
    Infect Immun; 2005 Aug; 73(8):5256-61. PubMed ID: 16041052
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Relationship between bacterial virulence and nucleotide metabolism: a mutation in the adenylate kinase gene renders Yersinia pestis avirulent.
    Munier-Lehmann H; Chenal-Francisque V; Ionescu M; Chrisova P; Foulon J; Carniel E; Bârzu O
    Biochem J; 2003 Jul; 373(Pt 2):515-22. PubMed ID: 12879903
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Study of protective properties of antigen-containing liposomes of different lipid composition in plague].
    Zakrevskiĭ VI; Plekhanova NG
    Vestn Akad Med Nauk SSSR; 1990; (8):41-4. PubMed ID: 2275277
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Biological properties of the native and synthetic lipid A of Porphyromonas gingivalis lipopolysaccharide.
    Kumada H; Haishima Y; Watanabe K; Hasegawa C; Tsuchiya T; Tanamoto K; Umemoto T
    Oral Microbiol Immunol; 2008 Feb; 23(1):60-9. PubMed ID: 18173800
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Characterisation of Yersinia pestis isolates from natural foci of plague in the Republic of Georgia, and their relationship to Y. pestis isolates from other countries.
    Revazishvili T; Rajanna C; Bakanidze L; Tsertsvadze N; Imnadze P; O'Connell K; Kreger A; Stine OC; Morris JG; Sulakvelidze A
    Clin Microbiol Infect; 2008 May; 14(5):429-36. PubMed ID: 18294239
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Toll-like receptor 4 initiates an innate immune response to lipopolysaccharide in human conjunctival epithelial cells.
    Chung SH; Kweon MN; Lee HK; Choi SI; Yang JY; Kim EK
    Exp Eye Res; 2009 Jan; 88(1):49-56. PubMed ID: 18951893
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Identification and characterization of autotransporter proteins of Yersinia pestis KIM.
    Yen YT; Karkal A; Bhattacharya M; Fernandez RC; Stathopoulos C
    Mol Membr Biol; 2007; 24(1):28-40. PubMed ID: 17453411
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Infectious-toxic model of plague in mice].
    Ryzhko IV; Mishan'kin BN; Tsuraeva RI; Shcherbaniuk AI; Anisimov BI
    Zh Mikrobiol Epidemiol Immunobiol; 2009; (3):46-50. PubMed ID: 19621819
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Early evolutionary loss of the lipid A modifying enzyme PagP resulting in innate immune evasion in
    Chandler CE; Harberts EM; Pelletier MR; Thaipisuttikul I; Jones JW; Hajjar AM; Sahl JW; Goodlett DR; Pride AC; Rasko DA; Trent MS; Bishop RE; Ernst RK
    Proc Natl Acad Sci U S A; 2020 Sep; 117(37):22984-22991. PubMed ID: 32868431
    [TBL] [Abstract][Full Text] [Related]  

  • 52. TLR4 and MyD88 control protection and pulmonary granulocytic recruitment in a murine intranasal RSV immunization and challenge model.
    Cyr SL; Angers I; Guillot L; Stoica-Popescu I; Lussier M; Qureshi S; Burt DS; Ward BJ
    Vaccine; 2009 Jan; 27(3):421-30. PubMed ID: 19013492
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [The use of inbred mice for studying the protective properties of Yersinia pestis antigens].
    Zadumina SIu; Nazarova LS; Isupov IV; Pavlova LP; Tikhomirova EI
    Zh Mikrobiol Epidemiol Immunobiol; 1995; (6):69-70. PubMed ID: 8553769
    [No Abstract]   [Full Text] [Related]  

  • 54. A plant-produced plague vaccine candidate confers protection to monkeys.
    Mett V; Lyons J; Musiychuk K; Chichester JA; Brasil T; Couch R; Sherwood R; Palmer GA; Streatfield SJ; Yusibov V
    Vaccine; 2007 Apr; 25(16):3014-7. PubMed ID: 17287055
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A new purification strategy for fraction 1 capsular antigen and its efficacy against Yersinia pestis virulent strain challenge.
    Wang T; Qi Z; Wu B; Zhu Z; Yang Y; Cui B; Dai R; Zhang Q; Qiu Y; Wang Z; Wang H; Guo Z; Wang X; Yang R
    Protein Expr Purif; 2008 Sep; 61(1):7-12. PubMed ID: 18539482
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Yersinia pestis factors, assuring circulation and maintenance of the plague pathogen in natural foci ecosystems. Report 1].
    Anisimov AP
    Mol Gen Mikrobiol Virusol; 2002; (3):3-23. PubMed ID: 12243063
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The structure of Yersinia pestis Caf1 polymer in free and adjuvant bound states.
    Soliakov A; Harris JR; Watkinson A; Lakey JH
    Vaccine; 2010 Aug; 28(35):5746-54. PubMed ID: 20600492
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Weak anamnestic responses of inbred mice to Yersinia F1 genetic vaccine are overcome by boosting with F1 polypeptide while outbred mice remain nonresponsive.
    Brandler P; Saikh KU; Heath D; Friedlander A; Ulrich RG
    J Immunol; 1998 Oct; 161(8):4195-200. PubMed ID: 9780193
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Morphological study of the damaging effect of an EB vaccine strain of the plague microbe in inbred mice].
    Nazarova LS; Isupov IV; Pavlova LP; Gor'kova AV; Dushkin VA
    Biull Eksp Biol Med; 1988 Jun; 105(6):761-4. PubMed ID: 3390604
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Transcriptional responses in spleens from mice exposed to Yersinia pestis CO92.
    Rogers JV; Choi YW; Giannunzio LF; Sabourin PJ; Bornman DM; Blosser EG; Sabourin CL
    Microb Pathog; 2007; 43(2-3):67-77. PubMed ID: 17531433
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.